Natriuretic peptide pharmacogenetics: Membrane metallo-endopeptidase (MME): Common gene sequence variation, functional characterization and degradation

Journal of Molecular and Cellular Cardiology

Volumn 49, Issue 5, 2010, Pages 864-874

  Pereira, Naveen L ^a   Aksoy, Pinar ^d   Moon, Irene ^b   Peng, Yi ^c   Redfield, Margaret M ^a   Burnett, John C ^a   Wieben, Eric D ^b   Yee, Vivien C ^c   Weinshilboum, Richard M ^b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Membrane metallo endopeptidase; Natriuretic peptides; Pharmacogenetics; Polymorphism

Indexed keywords

ALANINE; ALLOENZYME; ARGININE; ASPARTIC ACID; BRAIN NATRIURETIC PEPTIDE; DNA; GLUCOSE REGULATED PROTEIN 78; GLUCOSE REGULATED PROTEIN 94; GLYCINE; ISOLEUCINE; LEUCINE; MEMBRANE METALLOENDOPEPTIDASE; METHIONINE; PROLINE; PROTEASOME; RECOMBINANT PROTEIN; SERINE; VALINE;

AFRICAN AMERICAN; AGGRESOME; ALLELE; ANIMAL CELL; ARTICLE; ASIAN AMERICAN; AUTOPHAGY; CONTROLLED STUDY; ENZYME ACTIVITY; ETHNIC GROUP; EUROPEAN AMERICAN; FLUOROMETRY; GENE CONSTRUCT; GENE EXPRESSION; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC IDENTIFICATION; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; GENETIC VARIABILITY; HAPLOTYPE; HEART FUNCTION; HUMAN; IMMUNOREACTIVITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHARMACOGENETICS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FOLDING; QUANTITATIVE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STRUCTURE ANALYSIS; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ATRIAL NATRIURETIC FACTOR; AUTOPHAGY; BASE SEQUENCE; CERCOPITHECUS AETHIOPS; COS CELLS; GENETIC VARIATION; GENOMICS; HAPLOTYPES; HUMANS; ISOENZYMES; LINKAGE DISEQUILIBRIUM; MODELS, MOLECULAR; MOLECULAR CHAPERONES; NEPRILYSIN; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN PROCESSING, POST-TRANSLATIONAL; SEQUENCE ANALYSIS, DNA; VALINE;

EID: 77957228322     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.07.020     Document Type: Article

References (40)

1. Munagala V.K., Burnett J.C., Redfield M.M. The natriuretic peptides in cardiovascular medicine. Curr Probl Cardiol 2004, 29(12):707-769.
2. Rademaker MT, Charles CJ, Kosoglou T, Protter AA, Espiner EA, Nicholls MG, et al. Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure. Am J Physiol 1997 Nov;273(5 Pt 2). 1997; 273(5 Pt 2): H2372-9.
3. Lanfear D.E., Stolker J.M., Marsh S., Rich M.W., McLeod H.L. Genetic variation in the B-type natriuretic peptide pathway affects BNP levels. Cardiovasc Drugs Ther 2007, 21(1):55-62.
4. Dao Q., Krishnaswamy P., Kazanegra R., Harrison A., Amirnovin R., Lenert L., et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 2001, 37(2):379-385.
5. Colucci W.S., Elkayam U., Horton D.P., Abraham W.T., Bourge R.C., et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. N Engl J Med 2000, 343(4):246-253. Nesiritide Study Group.
6. Florkowski C.M., Richards A.M., Espiner E.A., Yandle T.G., Sybertz E., Frampton C.M. Low-dose brain natriuretic peptide infusion in normal men and the influence of endopeptidase inhibition. Clin Sci (Lond) 1997, 92(3):255-260.
7. Corti R., Burnett J.C., Rouleau J.L., Ruschitzka F., Lüscher T.F. Vasopeptidase inhibitors: a new therapeutic concept in cardiovascular disease?. Circulation 2001, 104(15):1856-1862.
8. Wang L., Weinshilboum R.M. Pharmacogenomics: candidate gene identification, functional validation and mechanisms. Hum Mol Genet 2008, 17(R2):R174-R179.
9. Turner A.J., Isaac R.E., Coates D. The neprilysin (NEP) family of zinc metalloendopeptidases: genomics and function. Bioessays 2001, 23(3):261-269.
10. D'Adamio L., Shipp M.A., Masteller E.L., Reinherz E.L. Organization of the gene encoding common acute lymphoblastic leukemia antigen (neutral endopeptidase 24.11): multiple miniexons and separate 5' untranslated regions. Proc Natl Acad Sci USA 1989, 86(18):7103-7107.
11. Florentin D., Sassi A., Roques B.P. A highly sensitive fluorometric assay for "enkephalinase," a neutral metalloendopeptidase that releases tyrosine-glycine-glycine from enkephalins. Anal Biochem 1984, 141(1):62-69.
12. Oefner C., D'Arcy A., Hennig M., Winkler F.K., Dale G.E. Structure of human neutral endopeptidase (Neprilysin) complexed with phosphoramidon. J Mol Biol 2000, 296(2):341-349.
13. Emsley P., Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 2004, 60(Pt 12 Pt 1):2126-2132.
14. Kraulis P.J. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J Appl Cryst 1991, 24(5):946-950.
15. Merritt E.A., Bacon D.J. Raster3D: photorealistic molecular graphics. Meth Enzymol 1997, 505-524.
16. van der Spoel D., Lindahl E., Hess B., Groenhof G., Mark A.E., Berendsen H.J.C. GROMACS: fast, flexible and free. J Comp Chem 2005, 26:1701-1718.
17. van Gunsteren W.F., Berendsen H.J.C. Gromos-87 manual. AG Groningen, The Netherlands. Biomos BV Nijenborgh 1987, 4:9747.
18. Tajima F. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics Nov 1989, 123(3):585-595.
19. Hartl D.L., Clark A.G. Organization of genetic variation 2000, Sinauer Associates, Sunderland, MA. 3rd ed.
20. Hendrick P. Genetics of populations 2000, Jones and Bartlett Publishers, Sudbury, Massachusetts. 3rd ed.
21. Schaid D.J., Rowland C.M., Tines D.E., Jacobson R.M., Poland G.A. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002 Feb, 70(2):425-434.
22. Long J.C., Williams R.C., Urbanek M. An E-M algorithm and testing strategy for multiple-locus haplotypes. Am J Hum Genet 1995, 56(3):799-810.
23. Wang L., Weinshilboum R. Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directions. Oncogene 2006, 25(11):1629-1638.
24. Bence N.F., Sampat R.M., Kopito R.R. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 2001, 292(5521):1552-1555.
25. Melnick J., Aviel S., Argon Y. The endoplasmic reticulum stress protein GRP94, in addition to BiP, associates with unassembled immunoglobulin chains. J Biol Chem 1992, 267(30):21303-21306.
26. Roques B.P. Cell surface metallopeptidases involved in blood pressure regulation: structure, inhibition and clinical perspectives. Pathol Biol (Paris) 1998, 46(3):191-200.
27. Fielitz J., Dendorfer A., Pregla R., Ehler E., Zurbrügg H.R., Bartunek J., et al. Neutral endopeptidase is activated in cardiomyocytes in human aortic valve stenosis and heart failure. Circulation 2002, 105(3):286-289.
28. Knecht M., Pagel I., Langenickel T., Philipp S., Scheuermann-Freestone M., Willnow T., et al. Increased expression of renal neutral endopeptidase in severe heart failure. Life Sci 2002, 71(23):2701-2712.
29. Helske S., Laine M., Kupari M., Lommi J., Turto H., Nurmi L., et al. Increased expression of profibrotic neutral endopeptidase and bradykinin type 1 receptors in stenotic aortic valves. Eur Heart J 2007, 28(15):1894-1903.
30. Comings D.E., Dietz G., Gade-Andavolu R., Blake H., Muhleman D., Huss M., et al. Association of the neutral endopeptidase (MME) gene with anxiety. Psychiatr Genet 2000, 10(2):91-94.
31. Yamada M., Sodeyama N., Itoh Y., Takahashi A., Otomo E., Matsushita M., et al. Association of neprilysin polymorphism with cerebral amyloid angiopathy. J Neurol Neurosurg Psychiatry 2009, 74(6):749-751.
32. Debiec H., Nauta J., Coulet F., van der Burg M., Guigonis V., Schurmans T., et al. Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies. Lancet 2004, 364(9441):1252-1259.
33. Rubattu S., Stanzione R., Di Angelantonio E., Zanda B., Evangelista A., Tarasi D., et al. Atrial natriuretic peptide gene polymorphisms and risk of ischemic stroke in humans. Stroke 2004, 35(4):814-818.
34. Sarzani R., Dessì-Fulgheri P., Salvi F., Serenelli M., Spagnolo D., Cola G., et al. A novel promoter variant of the natriuretic peptide clearance receptor gene is associated with lower atrial natriuretic peptide and higher blood pressure in obese hypertensives. J Hypertens 1999, 17(9):1301-1305.
35. Lynch A.I., Boerwinkle E., Davis B.R., Ford C.E., Eckfeldt J.H., Leiendecker-Foster C., et al. Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension. JAMA 2008, 299(3):296-307.
36. Aksoy P., Zhu M.J., Kalari K.R., Moon I., Pelleymounter L.L., Eckloff B.W., et al. Cytosolic 5'-nucleotidase III (NT5C3): gene sequence variation and functional genomics. Pharmacogenet Genomics 2009, 19(8):567-576.
37. Hartman W.R., Pelleymounter L.L., Moon I., Kalari K., Liu M., Wu T.Y., et al. CD38 expression, function, and gene resequencing in a human lymphoblastoid cell line-based model system. Leuk Lymphoma 2010, 51(7):1315-1325.
38. Li F., Feng Q., Lee C., Wang S., Pelleymounter L.L., Moon I., et al. Human betaine-homocysteine methyltransferase (BHMT) and BHMT2: common gene sequence variation and functional characterization. Mol Genet Metab 2008, 94(3):326-335.
39. Bodmer W., Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 2008, 40(6):695-701.
40. Surolia I., Pirnie S.P., Chellappa V., Taylor K.N., Cariappa A., Moya J., et al. Functionally defective germline variants of sialic acid acetylesterase in autoimmunity. Nature 2010, 466(7303):243-247.